exhibit 10. 1 exhibit 10. 1 service agreement this independent contractor agreement ( “ agreement ” ) is entered into this 27th day of july 2013 between dr. wei ping min ( “ min ” ), a research scientist ( hereinafter referred to as “ contractor ” ) whose address is 84 hesketh street, london ontario n6g5h5, canada and regen biopharma, inc. ( hereinafter referred to as “ client ” ), a nevada corporation with offices at 4700 spring street, suite 304, la mesa, ca 91942. whereas : a. contractor is a scientific researcher in the area of biological sciences. a. contractor is a scientific researcher in the area of biological sciences. b. contractor is experienced and knowledgeable with regard to the conducting scientific research in the area of aplastic anemia. b. contractor is experienced and knowledgeable with regard to the conducting scientific research in the area of aplastic anemia. now therefore, in consideration of the mutual promises and conditions contained herein, the parties agree as follows : article 1 duration of contract section 1. 1 this agreement is effective july 27, 2013 and will continue in effect until june 30, 2014, unless terminated in accordance with the provisions of article 7 of this agreement. section 1. 2 this agreement may be extended by mutual consent of said parties. article 2 independent contractor status section 2. 1 it is the express intention of the parties that contractor is an independent contractor and not an employee, agent, joint venture participant, or partner of client. nothing in this agreement shall be interpreted or construed as creating or establishing the relationship of employer and employee between client and contractor or any employee or agent of contractor. both parties acknowledge that contractor is not an employee for state or federal tax purposes. contractor shall retain the right to perform services for others during the term of this agreement. section 2. 2. client acknowledges and agrees that contractor shall have the right to engage in other independent scientific activities. article 3 services performed by contractor section 3. 1 participate in discussions with fda and provide experimental support. section 3. 2 execution of fda suggested additional experiment : ( a ) 8 - 12 week female b6 mice will be treated with interperitoneal injection of 150mg / kg 5 - fu ( a ) 8 - 12 week female b6 mice will be treated with interperitoneal injection of 150mg / kg 5 - fu ( b ) groups of mice